STAT3 and renal cell carcinoma: The signal transducer and activator of transcription-3 (STAT3) pathway is also deregulated in human RCC [10] and STAT3 has been reported to act as a potent regulator of HIF-1α and HIF-2α expression [11] and as a modulator of HIF-1-mediated response [12].